Tetracycline
تتراسایکلین
🦠 Antiinfectives For Systemic UseTetracycline antibiotic
Market / country: 🇺🇸 USA
Sumycin (US)
🧮 Dose calculator
Susceptible bacterial infections (general) · Regimen source: FDA Tetracycline caps. · Dosage and Administration — Adults
- • Severe infection: 500 mg four times daily. With plenty of water; separate from dairy, antacids and iron. FDA Tetracycline caps. · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to tetracyclines. FDA Tetracycline caps. · Contraindications
- ⚠️ Under 8 years (permanent tooth discoloration). FDA Tetracycline caps. · Warnings
Formulations
- 250 mg capsule — capsule 🇺🇸 USA FDA Tetracycline caps. · How Supplied
- 500 mg capsule — capsule 🇺🇸 USA FDA Tetracycline caps. · How Supplied
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Tetracycline caps. · Pregnancy
“Teratogenic Effects Pregnancy Category D (see WARNINGS ) Nonteratogenic Effects (see WARNINGS ) Pregnant women with renal disease may be more prone to develop tetracycline-associated liver failure.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Tetracycline caps. · Nursing Mothers
“Because of potential for serious adverse reaction in nursing infants from tetracyclines, a decision should be made whether to discontinue the drug, taking into account the importance of the drug to the mother (see WARNINGS ).”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Tetracycline caps. · Pediatric Use
“See WARNINGS and DOSAGE AND ADMINISTRATION .”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA210662
- DailyMed (FDA label)FDA Tetracycline caps.
- MedlinePlus (NIH)Tetracycline
- WHO ATC/DDDJ01AA07
- Darooyab (Iran)Tetracycline
🇮🇷 Registered in Iran Darooyab · G-548/Tetracycline
Dosage forms with Iranian generic codes, per Darooyab.
- 01207 · TETRACYCLINE 250MG CAP · کپسول تتراسایکلین ۲۵۰ میلیگرم
- 01208 · TETRACYCLINE 3% OINT · پماد تتراسایکلین ۳ درصد
- 52979 · TETRACYCLINE HYDROCHLORIDE OINTMENT TOPICAL 3 % 30 g · پماد تتراسایکلین هیدروکلراید ۳ درصد ۳۰ گرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Tetracycline caps. · How SuppliedFDA Tetracycline caps. · Dosage and Administration — AdultsFDA Tetracycline caps. · Dosage and AdministrationFDA Tetracycline caps. · Dosage and Administration — pediatric patients above eight yearsFDA Tetracycline caps. · ContraindicationsFDA Tetracycline caps. · WarningsFDA Tetracycline caps. · PregnancyFDA Tetracycline caps. · Nursing MothersFDA Tetracycline caps. · Pediatric UseFDA Tetracycline caps. · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-548/Tetracycline
- Clinical review⚠ Unverified